Financial Snapshot

Revenue
$1.593B
TTM
Gross Margin
4.95%
TTM
Net Earnings
-$10.01M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
135.71%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$54.09M
Q3 2024
Cash
Q3 2024
P/E
-19.32
Nov 29, 2024 EST
Free Cash Flow
$26.29M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020
Revenue $1.279B $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020
Revenue $1.279B $0.00 $0.00 $0.00
Cost Of Revenue $1.196B $1.054B $865.8M $658.6M
Gross Profit $82.80M -$1.054B -$865.8M -$658.6M
Gross Profit Margin 6.47%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020
Selling, General & Admin $93.51M
YoY Change
% of Gross Profit 112.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.450M $6.719M $6.079M $3.656M
YoY Change 25.76% 10.53% 66.27%
% of Gross Profit 10.21%
Operating Expenses $100.7M $4.780M $3.265M $0.00
YoY Change 2007.08% 46.4%
Operating Profit -$17.92M -$2.390M -$1.632M $22.07M
YoY Change 649.74% 46.4% -107.4%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020
Interest Expense -$5.091M $5.268M $20.26K $1.116M
YoY Change -196.63% 25904.34% -98.18%
% of Operating Profit 5.06%
Other Income/Expense, Net -$8.262M $13.95M $10.03M $180.0K
YoY Change -159.23% 39.11% 5470.67%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020
Pretax Income -$62.51M $11.56M $16.79M $0.00
YoY Change -640.76% -31.15%
Income Tax $384.0K $1.027M $0.00 $0.00
% Of Pretax Income 8.88% 0.0%
Net Earnings -$9.125M $10.53M $8.395M $0.00
YoY Change -186.64% 25.47%
Net Earnings / Revenue -0.71%
Basic Earnings Per Share -$1.36 $0.00 $0.00 $0.00
Diluted Earnings Per Share -$1.37 $0.51 $479.9K $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020
Cash & Short-Term Investments $63.93M $374.3K $803.3K $0.00
YoY Change 16979.35% -53.41%
Cash & Equivalents $28.54M
Short-Term Investments $35.39M
Other Short-Term Assets $4.277M $86.62K $468.6K
YoY Change 4837.66% -81.51%
Inventory $44.57M
Prepaid Expenses
Receivables $130.8M
Other Receivables $34.27M
Total Short-Term Assets $277.8M $460.9K $1.272M $0.00
YoY Change 60171.41% -63.76%
Property, Plant & Equipment $83.79M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $338.4M $333.5M
YoY Change 1.47%
Other Assets $10.48M $0.00 $86.86K $10.00K
YoY Change -100.0% 768.6%
Total Long-Term Assets $96.65M $338.4M $333.6M $10.00K
YoY Change -71.44% 1.44% 3335971.1%
Total Assets $374.5M $338.9M $334.9M $10.00K
YoY Change
Accounts Payable $127.6M $2.606M $1.028M
YoY Change 4799.0% 153.34%
Accrued Expenses $35.88M $10.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.189M
YoY Change
Total Short-Term Liabilities $169.0M $2.606M $1.028M $10.00K
YoY Change 6387.93% 153.34% 10184.7%
Long-Term Debt $85.19M $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $49.51M $12.55M $21.23M
YoY Change 294.55% -40.89%
Total Long-Term Liabilities $134.7M $12.55M $21.23M $0.00
YoY Change 973.47% -40.89%
Total Liabilities $471.2M $15.73M $22.26M $10.00K
YoY Change 2895.87% -29.33% 222465.4%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020
Basic Shares Outstanding 6.686M shares 0.000 shares 0.000 shares
Diluted Shares Outstanding 6.686M shares 0.000 shares 0.000 shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $193.45 Million

About American Oncology Network, Inc.

American Oncology Network, Inc. engages in the provision of community-based oncology management. The company is headquartered in Fort Myers, Florida and currently employs 1,525 full-time employees. The company went IPO on 2021-03-10. The firm has offered a progressive model of physician-led, community-based oncology management. Its business is focused on caring for adult and senior populations with medical oncology and related care needs, including members of Medicare Advantage (MA) plan run by private insurance companies on behalf of the Centers for Medicare and Medicaid Services, or CMS, as well as traditional Fee-For-Service (FFS) Medicare, Medicaid, other government healthcare programs and commercial insurance populations. The company provides patients with a variety of services, including in-house professional and technical pathology providing complete pathology reports; in-house specialty pharmacy with patient education, financial assistance and 24/7 patient assistance, and care management support services including nutrition guidance. The firm's network represents more than 220 providers practicing across 20 states.

Industry: Services-Health Services Peers: Airsculpt Technologies, Inc. BIODESIX INC CVS HEALTH Corp P3 Health Partners Inc. InfuSystem Holdings, Inc Invitae Corp